Post-earnings recap
Reported
Thu, Oct 28, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported a strong earnings per share, significantly exceeding expectations, which contributed to a positive stock reaction. Investors responded favorably to the company's performance in key areas, despite the absence of revenue data and guidance. The stock's increase suggests confidence in the company's future prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.71 | N/A | +61.30% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook despite some ongoing challenges. They emphasized the strength of their product offerings.
Management highlighted strong performance in key product segments.
They noted ongoing challenges in the supply chain but expressed confidence in future growth.